136 related articles for article (PubMed ID: 8761944)
1. Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones.
Bautista DS; Denstedt J; Chambers AF; Harris JF
J Cell Biochem; 1996 Jun; 61(3):402-9. PubMed ID: 8761944
[TBL] [Abstract][Full Text] [Related]
2. Quantification of osteopontin in the urine of healthy and stone-forming men.
Yasui T; Fujita K; Hayashi Y; Ueda K; Kon S; Maeda M; Uede T; Kohri K
Urol Res; 1999 Aug; 27(4):225-30. PubMed ID: 10460890
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms.
Kon S; Maeda M; Segawa T; Hagiwara Y; Horikoshi Y; Chikuma S; Tanaka K; Rashid MM; Inobe M; Chambers AF; Uede T
J Cell Biochem; 2000 Apr; 77(3):487-98. PubMed ID: 10760956
[TBL] [Abstract][Full Text] [Related]
4. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
Langdon A; Grohe B
Colloids Surf B Biointerfaces; 2016 Oct; 146():296-306. PubMed ID: 27362921
[TBL] [Abstract][Full Text] [Related]
5. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
Huang HS; Ma MC; Chen CF; Chen J
Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin and calcium stone formation.
Kleinman JG; Wesson JA; Hughes J
Nephron Physiol; 2004; 98(2):p43-7. PubMed ID: 15499214
[TBL] [Abstract][Full Text] [Related]
7. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences.
Kon S; Yokosaki Y; Maeda M; Segawa T; Horikoshi Y; Tsukagoshi H; Rashid MM; Morimoto J; Inobe M; Shijubo N; Chambers AF; Uede T
J Cell Biochem; 2002; 84(2):420-32. PubMed ID: 11787071
[TBL] [Abstract][Full Text] [Related]
8. Improved immunohistochemical staining of osteopontin (OPN) in paraffin-embedded archival bone specimens following antigen retrieval: anti-human OPN antibody recognizes multiple molecular forms.
Devoll RE; Pinero GJ; Appelbaum ER; Dul E; Troncoso P; Butler WT; Farach-Carson MC
Calcif Tissue Int; 1997 Apr; 60(4):380-6. PubMed ID: 9075637
[TBL] [Abstract][Full Text] [Related]
9. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
Atmani F; Glenton PA; Khan SR
Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
[TBL] [Abstract][Full Text] [Related]
10. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women.
Bautista DS; Saad Z; Chambers AF; Tonkin KS; O'Malley FP; Singhal H; Tokmakejian S; Bramwell V; Harris JF
Clin Biochem; 1996 Jun; 29(3):231-9. PubMed ID: 8740509
[TBL] [Abstract][Full Text] [Related]
11. Expression, roles, receptors, and regulation of osteopontin in the kidney.
Xie Y; Sakatsume M; Nishi S; Narita I; Arakawa M; Gejyo F
Kidney Int; 2001 Nov; 60(5):1645-57. PubMed ID: 11703581
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
[TBL] [Abstract][Full Text] [Related]
13. Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity.
Vernon HJ; Osborne C; Tzortzaki EG; Yang M; Chen J; Rittling SR; Denhardt DT; Buyske S; Bledsoe SB; Evan AP; Fairbanks L; Simmonds HA; Tischfield JA; Sahota A
Kidney Int; 2005 Sep; 68(3):938-47. PubMed ID: 16105024
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is synthesized by uterine glands and a 45-kDa cleavage fragment is localized at the uterine-placental interface throughout ovine pregnancy.
Johnson GA; Burghardt RC; Joyce MM; Spencer TE; Bazer FW; Gray CA; Pfarrer C
Biol Reprod; 2003 Jul; 69(1):92-8. PubMed ID: 12606367
[TBL] [Abstract][Full Text] [Related]
15. [Structural characteristics of osteopontin for calcium oxalate crystal].
Umekawa T
Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):436-44. PubMed ID: 10349302
[TBL] [Abstract][Full Text] [Related]
16. Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells.
Shanmugam V; Chackalaparampil I; Kundu GC; Mukherjee AB; Mukherjee BB
Biochemistry; 1997 May; 36(19):5729-38. PubMed ID: 9153413
[TBL] [Abstract][Full Text] [Related]
17. Ovine osteopontin: II. Osteopontin and alpha(v)beta(3) integrin expression in the uterus and conceptus during the periimplantation period.
Johnson GA; Burghardt RC; Spencer TE; Newton GR; Ott TL; Bazer FW
Biol Reprod; 1999 Oct; 61(4):892-9. PubMed ID: 10491621
[TBL] [Abstract][Full Text] [Related]
18. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy.
Gang X; Ueki K; Kon S; Maeda M; Naruse T; Nojima Y
Am J Kidney Dis; 2001 Feb; 37(2):374-9. PubMed ID: 11157380
[TBL] [Abstract][Full Text] [Related]
19. Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone.
Tawada T; Fujita K; Sakakura T; Shibutani T; Nagata T; Iguchi M; Kohri K
Urol Res; 1999 Aug; 27(4):238-42. PubMed ID: 10460892
[TBL] [Abstract][Full Text] [Related]
20. A polymorphism of the osteopontin gene is related to urinary calcium stones.
Gao B; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
J Urol; 2005 Oct; 174(4 Pt 1):1472-6. PubMed ID: 16145474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
